Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Kentucky · 2025 Regular Session · Bill

SB 240: AN ACT relating to Ibogaine research in the Commonwealth.

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 240 is a bill introduced in the Kentucky Senate on February 18, 2025. According to its official title, it concerns: AN ACT relating to Ibogaine research in the Commonwealth. Most recent recorded action (February 20, 2025): to Health Services (S).

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Create new sections of KRS 218A to define terms; establish the intent of the General Assembly that ibogaine is worthy of clinical research, trials, and studies as a potential viable therapeutic treatment of opioid dependence and any other co-occurring mental health disorders; establish a trust and agency account entitled the ibogaine research fund; establish a process for private entities to apply to the Department of Agriculture for access to funds in the Ibogaine Research Fund.

Sponsors

NameRolePartyChamberDistrict
No sponsor recorded in source data.

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. to Health Services (S)
  2. to Committee on Committees (S)
  3. introduced in Senate

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source